Voloridge Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Voloridge Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28,840	Closed	-$2.08M	–	1771
2020 Q4	$2.08M	Sell	28,840 -6,311	-18%	-$330K	0.02%	725
2020 Q3	$1.6M	Buy	35,151 +30,722	+694%	+$1.28M	0.01%	792
2020 Q2	$200K	Buy	+4,429	New	+$198K	﹤0.01%	1197
2019 Q4	–	Sell	-21,745	Closed	-$886K	–	1481
2019 Q3	$886K	Sell	21,745 -18,140	-45%	-$783K	0.02%	666
2019 Q2	$1.92M	Buy	39,885 +9,926	+33%	+$522K	0.05%	333
2019 Q1	$1.88M	Buy	29,959 +15,927	+114%	+$1.09M	0.06%	310
2018 Q4	$838K	Buy	+14,032	New	+$842K	0.04%	290

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Voloridge Investment Management's BEAT Position: Q1 2021 in Review

Voloridge Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 28,840 shares — an estimated $2.08M sold.

Voloridge Investment Management first reported a position in BEAT in Q4 2018 and held it in 7 quarters. The position peaked at $2.08M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Voloridge Investment Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Voloridge Investment Management sold 28,840 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.08M.
Voloridge Investment Management first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 7 quarters.
Voloridge Investment Management's BioTelemetry, Inc. position peaked at $2.08M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Voloridge Investment Management's 13F filing for Q1 2021, filed 17 May 2021.